In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked ...

Pediatric kidney disease requires early diagnosis and specialized care to support growth, development, and long-term health.

Fortunately, eight days after surgery, I received the pathology report and was elated to read that it was an oncocytoma ...

Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.

Diabetic kidney disease affects a growing proportion of people with diabetes and remains the leading cause of end-stage renal ...

A new meta-analysis further supports the previously reported link between kidney stones and an increased risk for kidney ...

Novel research led by Brazilian scientists describes the immune system's reactions in detail in the first living patient to ...

In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked attenuation of kidney function loss, suggesting a potential disease-modifying e ...

As the health care delivery landscape continues to evolve, the need to advocate for policies that affect patients and the ...